- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
MBD1 Antibody (monoclonal) (M05)Purified Mouse Monoclonal Antibody (Mab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AT2812a | 100 ug 400 ul | 7-10 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
MBD1 Antibody (monoclonal) (M05) - Product info | |
| Application | WB
|
| Primary Accession | Q9UIS9 |
| Other Accession | NP_056671 |
| Reactivity | Human |
| Isotype | IgG2b Kappa |
| Clone Names | 2B10 |
| Calculated MW | 66607 Da |
MBD1 Antibody (monoclonal) (M05) - Additional info | |
| Gene ID 4152 | |
| Other Names CXXC3, PCM1, RFTmethyl-CpG binding domain protein 1 | |
| Target/Specificity MBD1 (NP_056671, 415 a.a. ~ 509 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. | |
| Dilution WB~~1:500~1000 | |
| Format Clear, colorless solution in phosphate buffered saline, pH 7.2 . | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions MBD1 Antibody (monoclonal) (M05) is for research use only and not for use in diagnostic or therapeutic procedures. | |
MBD1 Antibody (monoclonal) (M05) - Related products
AP1036a: MBD1 Antibody (N-term)
AP1036b: MBD1 Antibody (C-term)
LY10217a: PCM1 Over-expression Lysate
BP1036a: MBD1 Antibody (N-term) Blocking Peptide
BP1036b: MBD1 Antibody (C-term) Blocking Peptide
MBD1 Antibody (monoclonal) (M05) - Application data
-
MBD1 monoclonal antibody (M05), clone 2B10. Western Blot analysis of MBD1 expression in Jurkat ( Cat # L017V1 ).
MBD1 Antibody (monoclonal) (M05) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. Five transcript variants of the MBD1 are generated by alternative splicing resulting in protein isoforms that contain one MBD domain, two to three cysteine-rich (CXXC) domains, and some differences in the COOH terminus. All five transcript variants repress transcription from methylated promoters; in addition, variants with three CXXC domains also repress unmethylated promoter activity. MBD1 and MBD2 map very close to each other on chromosome 18q21.
REFERENCES
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Crowther-Swanepoel D, et al. Nat Genet, 2010 Feb. PMID 20062064.Human BAHD1 promotes heterochromatic gene silencing. Bierne H, et al. Proc Natl Acad Sci U S A, 2009 Aug 18. PMID 19666599.Methyl-CpG binding domain 1 gene polymorphisms and lung cancer risk in a Chinese population. Liu H, et al. Biomarkers, 2008 Sep. PMID 18668384.Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes. Yaqinuddin A, et al. Biosci Rep, 2008 Dec. PMID 18666890.Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference. Liu C, et al. BMC Cancer, 2008 Apr 29. PMID 18445260.
